Trials / Sponsors / Jun Zhang, MD, PhD
Jun Zhang, MD, PhD
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - Non-Small Cell Lung Cancer | Phase 2 | 2024-12-01 |
| Recruiting | Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC Lung Cancer, NSCLC, NSCLC Stage IV | — | 2022-07-21 |
| Unknown | Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy NSCLC Stage IV, NSCLC Stage IIIB | Phase 2 | 2021-09-14 |
| Recruiting | Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patien NSCLC, Stage III, Locally Advanced Lung Carcinoma | — | 2021-04-12 |
| Unknown | Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC) NSCLC Stage IV, NSCLC, Recurrent | — | 2020-07-29 |